Author:
Ehrke M. Jane,Mihich Enrico
Reference95 articles.
1. Acerbis, G., Cleris, L., Rodolfo, M., Parmiani, G., and Formelli, F., 1992, Post surgical adjuvant chemoimmunotherapy with recombinant interleukin-2 and l, 3-bis-(2-chloroethyl)-1-nitrosurea on spontaneous metastases of a non-immunogenic murine tumour, Cancer Immunol Immunother.34: 383–388.
2. Afonso, L. C. C., Scharton, T. M., Vieira, L. Q., Wysocka, M., Trinchieri, G., and Scott, P., 1994, The adjuvant effect of interleukin-2 in a vaccine against Leishmania major, Science 263: 235–237.
3. Allavena, P., Pirovano, P., Bonazzi, C., Colombo, N., Mantovani, A., and D’lnacalci, M., 1990, In vitro and in vivo effects of cisplatin on the generation of lymphokine-activated killer cells, J. Natl Cancer Inst.82: 139–142.
4. Allison, J. P. 1993, γδ T-cell development, Curr. Opin. Immunol.5: 241–246.
5. Arinaga, S., Akiyoshi, T., and Tsuji, H., 1985, Augmentation of the cell-mediated cytotoxic response induced in mixed cell culture by adriamycin, Jpn. J. Cancer Res.76: 414–419.